TOPCO SCIENTIFIC CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 275 TWD | +0.55% |
|
-0.18% | +50.68% |
| 05-30 | Taiwan minister says he's not concerned by China drills' impact on chip sector | RE |
| 05-23 | Topco Scientific Co.,Ltd. Announces Cash Dividend, Payable on July 19, 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 19,169 | 21,713 | 28,709 | 29,799 | 34,438 | 51,893 | - |
| Enterprise Value (EV) 1 | 17,449 | 19,891 | 26,931 | 27,021 | 33,018 | 48,691 | 46,695 |
| P/E ratio | 11.2 x | 10.6 x | 12.6 x | 9.99 x | 11.9 x | 15.4 x | 14.3 x |
| Yield | 6.16% | 6.69% | 5.57% | 6.1% | 4.93% | 3.89% | 4.4% |
| Capitalization / Revenue | 0.6 x | 0.6 x | 0.67 x | 0.56 x | 0.7 x | 0.93 x | 0.85 x |
| EV / Revenue | 0.55 x | 0.55 x | 0.63 x | 0.51 x | 0.67 x | 0.87 x | 0.77 x |
| EV / EBITDA | 8.23 x | 8.39 x | 9.18 x | 7.33 x | 8.98 x | 13.6 x | 10 x |
| EV / FCF | 12.1 x | 11.5 x | 12.3 x | 9.6 x | 27 x | 14.7 x | 11.6 x |
| FCF Yield | 8.28% | 8.72% | 8.14% | 10.4% | 3.7% | 6.78% | 8.6% |
| Price to Book | 2.02 x | 2.05 x | 2.48 x | 2.3 x | 2.28 x | 3.17 x | 2.88 x |
| Nbr of stocks (in thousands) | 181,700 | 181,700 | 181,700 | 181,700 | 188,700 | 188,700 | - |
| Reference price 2 | 105.5 | 119.5 | 158.0 | 164.0 | 182.5 | 275.0 | 275.0 |
| Announcement Date | 26/03/20 | 29/03/21 | 15/03/22 | 13/03/23 | 01/03/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 31,701 | 36,168 | 42,669 | 52,978 | 49,273 | 55,772 | 61,038 |
| EBITDA 1 | 2,121 | 2,369 | 2,932 | 3,686 | 3,677 | 3,577 | 4,668 |
| EBIT 1 | 1,845 | 2,062 | 2,552 | 3,230 | 3,198 | 4,039 | 4,373 |
| Operating Margin | 5.82% | 5.7% | 5.98% | 6.1% | 6.49% | 7.24% | 7.16% |
| Earnings before Tax (EBT) 1 | 2,208 | 2,559 | 3,040 | 4,242 | 3,880 | 4,627 | 4,997 |
| Net income 1 | 1,722 | 2,068 | 2,294 | 3,018 | 2,835 | 3,380 | 3,630 |
| Net margin | 5.43% | 5.72% | 5.38% | 5.7% | 5.75% | 6.06% | 5.95% |
| EPS 2 | 9.420 | 11.29 | 12.53 | 16.41 | 15.36 | 17.91 | 19.24 |
| Free Cash Flow 1 | 1,446 | 1,734 | 2,191 | 2,815 | 1,223 | 3,302 | 4,017 |
| FCF margin | 4.56% | 4.79% | 5.14% | 5.31% | 2.48% | 5.92% | 6.58% |
| FCF Conversion (EBITDA) | 68.15% | 73.17% | 74.74% | 76.37% | 33.26% | 92.31% | 86.04% |
| FCF Conversion (Net income) | 83.93% | 83.82% | 95.51% | 93.26% | 43.14% | 97.71% | 110.65% |
| Dividend per Share 2 | 6.500 | 8.000 | 8.800 | 10.00 | 9.000 | 10.71 | 12.09 |
| Announcement Date | 26/03/20 | 29/03/21 | 15/03/22 | 13/03/23 | 01/03/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 11,766 | 12,583 | 13,225 | 13,793 | 13,377 | 12,492 | 12,055 | 12,492 | 12,233 | 11,932 | 13,450 | 15,020 | 15,370 | 13,834 | 14,668 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT 1 | 730.8 | 714.4 | 778.9 | 977.9 | 758.7 | 711.7 | 732.9 | 947 | 806.6 | 874.6 | 938 | 1,094 | 1,132 | 927.5 | 1,007 |
| Operating Margin | 6.21% | 5.68% | 5.89% | 7.09% | 5.67% | 5.7% | 6.08% | 7.58% | 6.59% | 7.33% | 6.97% | 7.29% | 7.36% | 6.7% | 6.87% |
| Earnings before Tax (EBT) 1 | 866.5 | 916.3 | 1,188 | 1,229 | 907.9 | 950.5 | 956.7 | 1,065 | 908 | 1,054 | 1,088 | 1,224 | 1,262 | 1,094 | 1,192 |
| Net income 1 | 633.2 | 659.9 | 900.3 | 893.2 | 565.1 | 739.9 | 669.6 | 791.9 | 633.6 | 775 | 793.5 | 906 | 905 | 816.5 | 863.5 |
| Net margin | 5.38% | 5.24% | 6.81% | 6.48% | 4.22% | 5.92% | 5.55% | 6.34% | 5.18% | 6.5% | 5.9% | 6.03% | 5.89% | 5.9% | 5.89% |
| EPS 2 | 3.450 | 3.610 | 4.920 | 4.870 | 3.050 | 4.030 | 3.670 | 4.250 | 3.350 | 4.110 | 4.200 | 4.800 | 4.795 | 4.330 | 4.575 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 15/03/22 | 29/04/22 | 29/07/22 | 28/10/22 | 13/03/23 | 05/05/23 | 27/07/23 | 01/11/23 | 01/03/24 | 03/05/24 | - | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | 1,721 | 1,822 | 1,778 | 2,778 | 1,419 | 3,202 | 5,198 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 1,446 | 1,734 | 2,191 | 2,815 | 1,223 | 3,302 | 4,017 |
| ROE (net income / shareholders' equity) | 19.1% | 20.6% | 20.7% | 24.6% | 20.2% | 21.6% | 21.9% |
| ROA (Net income/ Total Assets) | 9.34% | 10.1% | 9.84% | 11% | 9.22% | 11.2% | 11.6% |
| Assets 1 | 18,439 | 20,546 | 23,313 | 27,527 | 30,758 | 30,174 | 31,297 |
| Book Value Per Share 2 | 52.40 | 58.20 | 63.80 | 71.30 | 80.10 | 86.90 | 95.50 |
| Cash Flow per Share | - | - | - | - | - | - | - |
| Capex 1 | 312 | 273 | 406 | 369 | 398 | 369 | 369 |
| Capex / Sales | 0.99% | 0.75% | 0.95% | 0.7% | 0.81% | 0.66% | 0.6% |
| Announcement Date | 26/03/20 | 29/03/21 | 15/03/22 | 13/03/23 | 01/03/24 | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
275
TWD
Average target price
284.7
TWD
Spread / Average Target
+3.52%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +50.68% | 1.6B | |
| +149.46% | 3,034B | |
| +62.90% | 771B | |
| +43.83% | 747B | |
| +10.04% | 262B | |
| +37.72% | 222B | |
| +14.12% | 177B | |
| +117.74% | 170B | |
| +54.12% | 146B | |
| -38.37% | 132B |
- Stock Market
- Equities
- 5434 Stock
- Financials Topco Scientific Co.,Ltd.
